Global Psoriasis Biologics Drugs Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Pull Down Attic Ladder market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Pull Down Attic Ladder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Pull Down Attic Ladder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Pull Down Attic Ladder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Pull Down Attic Ladder players cover Werner, Louisville Ladder, FAKRO, MSW, American Stairways, Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Pull Down Attic Ladder Industry Forecast” looks at past sales and reviews total world Pull Down Attic Ladder sales in 2024, providing a comprehensive analysis by region and market sector of projected Pull Down Attic Ladder sales for 2025 through 2031. With Pull Down Attic Ladder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pull Down Attic Ladder industry.
This Insight Report provides a comprehensive analysis of the global Pull Down Attic Ladder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pull Down Attic Ladder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pull Down Attic Ladder market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pull Down Attic Ladder and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pull Down Attic Ladder.
This report presents a comprehensive overview, market shares, and growth opportunities of Pull Down Attic Ladder market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Pull Down Attic Ladder market?
What factors are driving Pull Down Attic Ladder market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pull Down Attic Ladder market opportunities vary by end market size?
How does Pull Down Attic Ladder break out by Type, by Application?
The global Pull Down Attic Ladder market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Pull Down Attic Ladder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Pull Down Attic Ladder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Pull Down Attic Ladder is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Pull Down Attic Ladder players cover Werner, Louisville Ladder, FAKRO, MSW, American Stairways, Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Pull Down Attic Ladder Industry Forecast” looks at past sales and reviews total world Pull Down Attic Ladder sales in 2024, providing a comprehensive analysis by region and market sector of projected Pull Down Attic Ladder sales for 2025 through 2031. With Pull Down Attic Ladder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pull Down Attic Ladder industry.
This Insight Report provides a comprehensive analysis of the global Pull Down Attic Ladder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pull Down Attic Ladder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pull Down Attic Ladder market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pull Down Attic Ladder and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pull Down Attic Ladder.
This report presents a comprehensive overview, market shares, and growth opportunities of Pull Down Attic Ladder market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Wood
- Aluminum
- Steel
- Residential
- Commercial
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Werner
- Louisville Ladder
- FAKRO
- MSW
- American Stairways, Inc
- Dolle
- MARWIN
- Telesteps
- Duo-Safety Ladder Corporation
- Attic Ease
What is the 10-year outlook for the global Pull Down Attic Ladder market?
What factors are driving Pull Down Attic Ladder market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pull Down Attic Ladder market opportunities vary by end market size?
How does Pull Down Attic Ladder break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psoriasis Biologics Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Psoriasis Biologics Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Psoriasis Biologics Drugs by Country/Region, 2020, 2024 & 2031
2.2 Psoriasis Biologics Drugs Segment by Type
2.2.1 TNF-? Inhibitor
2.2.2 IL-12/23 Target Drug
2.2.3 IL-17 Target Drug
2.3 Psoriasis Biologics Drugs Sales by Type
2.3.1 Global Psoriasis Biologics Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Psoriasis Biologics Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Psoriasis Biologics Drugs Sale Price by Type (2020-2025)
2.4 Psoriasis Biologics Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Psoriasis Biologics Drugs Sales by Application
2.5.1 Global Psoriasis Biologics Drugs Sale Market Share by Application (2020-2025)
2.5.2 Global Psoriasis Biologics Drugs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Psoriasis Biologics Drugs Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Psoriasis Biologics Drugs Breakdown Data by Company
3.1.1 Global Psoriasis Biologics Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Psoriasis Biologics Drugs Sales Market Share by Company (2020-2025)
3.2 Global Psoriasis Biologics Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Psoriasis Biologics Drugs Revenue by Company (2020-2025)
3.2.2 Global Psoriasis Biologics Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Psoriasis Biologics Drugs Sale Price by Company
3.4 Key Manufacturers Psoriasis Biologics Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Psoriasis Biologics Drugs Product Location Distribution
3.4.2 Players Psoriasis Biologics Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PSORIASIS BIOLOGICS DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Psoriasis Biologics Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Psoriasis Biologics Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Psoriasis Biologics Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Psoriasis Biologics Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Psoriasis Biologics Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Psoriasis Biologics Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Psoriasis Biologics Drugs Sales Growth
4.4 APAC Psoriasis Biologics Drugs Sales Growth
4.5 Europe Psoriasis Biologics Drugs Sales Growth
4.6 Middle East & Africa Psoriasis Biologics Drugs Sales Growth
5 AMERICAS
5.1 Americas Psoriasis Biologics Drugs Sales by Country
5.1.1 Americas Psoriasis Biologics Drugs Sales by Country (2020-2025)
5.1.2 Americas Psoriasis Biologics Drugs Revenue by Country (2020-2025)
5.2 Americas Psoriasis Biologics Drugs Sales by Type (2020-2025)
5.3 Americas Psoriasis Biologics Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psoriasis Biologics Drugs Sales by Region
6.1.1 APAC Psoriasis Biologics Drugs Sales by Region (2020-2025)
6.1.2 APAC Psoriasis Biologics Drugs Revenue by Region (2020-2025)
6.2 APAC Psoriasis Biologics Drugs Sales by Type (2020-2025)
6.3 APAC Psoriasis Biologics Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Psoriasis Biologics Drugs by Country
7.1.1 Europe Psoriasis Biologics Drugs Sales by Country (2020-2025)
7.1.2 Europe Psoriasis Biologics Drugs Revenue by Country (2020-2025)
7.2 Europe Psoriasis Biologics Drugs Sales by Type (2020-2025)
7.3 Europe Psoriasis Biologics Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psoriasis Biologics Drugs by Country
8.1.1 Middle East & Africa Psoriasis Biologics Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Psoriasis Biologics Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Psoriasis Biologics Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Psoriasis Biologics Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Psoriasis Biologics Drugs
10.3 Manufacturing Process Analysis of Psoriasis Biologics Drugs
10.4 Industry Chain Structure of Psoriasis Biologics Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Psoriasis Biologics Drugs Distributors
11.3 Psoriasis Biologics Drugs Customer
12 WORLD FORECAST REVIEW FOR PSORIASIS BIOLOGICS DRUGS BY GEOGRAPHIC REGION
12.1 Global Psoriasis Biologics Drugs Market Size Forecast by Region
12.1.1 Global Psoriasis Biologics Drugs Forecast by Region (2026-2031)
12.1.2 Global Psoriasis Biologics Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Psoriasis Biologics Drugs Forecast by Type (2026-2031)
12.7 Global Psoriasis Biologics Drugs Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen Psoriasis Biologics Drugs Product Portfolios and Specifications
13.1.3 Amgen Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
13.2 UCB
13.2.1 UCB Company Information
13.2.2 UCB Psoriasis Biologics Drugs Product Portfolios and Specifications
13.2.3 UCB Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 UCB Main Business Overview
13.2.5 UCB Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Psoriasis Biologics Drugs Product Portfolios and Specifications
13.3.3 Johnson & Johnson Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Abbive
13.4.1 Abbive Company Information
13.4.2 Abbive Psoriasis Biologics Drugs Product Portfolios and Specifications
13.4.3 Abbive Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Abbive Main Business Overview
13.4.5 Abbive Latest Developments
13.5 Innovent
13.5.1 Innovent Company Information
13.5.2 Innovent Psoriasis Biologics Drugs Product Portfolios and Specifications
13.5.3 Innovent Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Innovent Main Business Overview
13.5.5 Innovent Latest Developments
13.6 Biocad
13.6.1 Biocad Company Information
13.6.2 Biocad Psoriasis Biologics Drugs Product Portfolios and Specifications
13.6.3 Biocad Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Biocad Main Business Overview
13.6.5 Biocad Latest Developments
13.7 Novartis
13.7.1 Novartis Company Information
13.7.2 Novartis Psoriasis Biologics Drugs Product Portfolios and Specifications
13.7.3 Novartis Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Novartis Main Business Overview
13.7.5 Novartis Latest Developments
13.8 Eli Lilly
13.8.1 Eli Lilly Company Information
13.8.2 Eli Lilly Psoriasis Biologics Drugs Product Portfolios and Specifications
13.8.3 Eli Lilly Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Eli Lilly Main Business Overview
13.8.5 Eli Lilly Latest Developments
13.9 Sun Pharmaceutical
13.9.1 Sun Pharmaceutical Company Information
13.9.2 Sun Pharmaceutical Psoriasis Biologics Drugs Product Portfolios and Specifications
13.9.3 Sun Pharmaceutical Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Sun Pharmaceutical Main Business Overview
13.9.5 Sun Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psoriasis Biologics Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Psoriasis Biologics Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Psoriasis Biologics Drugs by Country/Region, 2020, 2024 & 2031
2.2 Psoriasis Biologics Drugs Segment by Type
2.2.1 TNF-? Inhibitor
2.2.2 IL-12/23 Target Drug
2.2.3 IL-17 Target Drug
2.3 Psoriasis Biologics Drugs Sales by Type
2.3.1 Global Psoriasis Biologics Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Psoriasis Biologics Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Psoriasis Biologics Drugs Sale Price by Type (2020-2025)
2.4 Psoriasis Biologics Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Psoriasis Biologics Drugs Sales by Application
2.5.1 Global Psoriasis Biologics Drugs Sale Market Share by Application (2020-2025)
2.5.2 Global Psoriasis Biologics Drugs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Psoriasis Biologics Drugs Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Psoriasis Biologics Drugs Breakdown Data by Company
3.1.1 Global Psoriasis Biologics Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Psoriasis Biologics Drugs Sales Market Share by Company (2020-2025)
3.2 Global Psoriasis Biologics Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Psoriasis Biologics Drugs Revenue by Company (2020-2025)
3.2.2 Global Psoriasis Biologics Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Psoriasis Biologics Drugs Sale Price by Company
3.4 Key Manufacturers Psoriasis Biologics Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Psoriasis Biologics Drugs Product Location Distribution
3.4.2 Players Psoriasis Biologics Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PSORIASIS BIOLOGICS DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Psoriasis Biologics Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Psoriasis Biologics Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Psoriasis Biologics Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Psoriasis Biologics Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Psoriasis Biologics Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Psoriasis Biologics Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Psoriasis Biologics Drugs Sales Growth
4.4 APAC Psoriasis Biologics Drugs Sales Growth
4.5 Europe Psoriasis Biologics Drugs Sales Growth
4.6 Middle East & Africa Psoriasis Biologics Drugs Sales Growth
5 AMERICAS
5.1 Americas Psoriasis Biologics Drugs Sales by Country
5.1.1 Americas Psoriasis Biologics Drugs Sales by Country (2020-2025)
5.1.2 Americas Psoriasis Biologics Drugs Revenue by Country (2020-2025)
5.2 Americas Psoriasis Biologics Drugs Sales by Type (2020-2025)
5.3 Americas Psoriasis Biologics Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psoriasis Biologics Drugs Sales by Region
6.1.1 APAC Psoriasis Biologics Drugs Sales by Region (2020-2025)
6.1.2 APAC Psoriasis Biologics Drugs Revenue by Region (2020-2025)
6.2 APAC Psoriasis Biologics Drugs Sales by Type (2020-2025)
6.3 APAC Psoriasis Biologics Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Psoriasis Biologics Drugs by Country
7.1.1 Europe Psoriasis Biologics Drugs Sales by Country (2020-2025)
7.1.2 Europe Psoriasis Biologics Drugs Revenue by Country (2020-2025)
7.2 Europe Psoriasis Biologics Drugs Sales by Type (2020-2025)
7.3 Europe Psoriasis Biologics Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psoriasis Biologics Drugs by Country
8.1.1 Middle East & Africa Psoriasis Biologics Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Psoriasis Biologics Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Psoriasis Biologics Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Psoriasis Biologics Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Psoriasis Biologics Drugs
10.3 Manufacturing Process Analysis of Psoriasis Biologics Drugs
10.4 Industry Chain Structure of Psoriasis Biologics Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Psoriasis Biologics Drugs Distributors
11.3 Psoriasis Biologics Drugs Customer
12 WORLD FORECAST REVIEW FOR PSORIASIS BIOLOGICS DRUGS BY GEOGRAPHIC REGION
12.1 Global Psoriasis Biologics Drugs Market Size Forecast by Region
12.1.1 Global Psoriasis Biologics Drugs Forecast by Region (2026-2031)
12.1.2 Global Psoriasis Biologics Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Psoriasis Biologics Drugs Forecast by Type (2026-2031)
12.7 Global Psoriasis Biologics Drugs Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen Psoriasis Biologics Drugs Product Portfolios and Specifications
13.1.3 Amgen Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
13.2 UCB
13.2.1 UCB Company Information
13.2.2 UCB Psoriasis Biologics Drugs Product Portfolios and Specifications
13.2.3 UCB Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 UCB Main Business Overview
13.2.5 UCB Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Psoriasis Biologics Drugs Product Portfolios and Specifications
13.3.3 Johnson & Johnson Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Abbive
13.4.1 Abbive Company Information
13.4.2 Abbive Psoriasis Biologics Drugs Product Portfolios and Specifications
13.4.3 Abbive Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Abbive Main Business Overview
13.4.5 Abbive Latest Developments
13.5 Innovent
13.5.1 Innovent Company Information
13.5.2 Innovent Psoriasis Biologics Drugs Product Portfolios and Specifications
13.5.3 Innovent Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Innovent Main Business Overview
13.5.5 Innovent Latest Developments
13.6 Biocad
13.6.1 Biocad Company Information
13.6.2 Biocad Psoriasis Biologics Drugs Product Portfolios and Specifications
13.6.3 Biocad Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Biocad Main Business Overview
13.6.5 Biocad Latest Developments
13.7 Novartis
13.7.1 Novartis Company Information
13.7.2 Novartis Psoriasis Biologics Drugs Product Portfolios and Specifications
13.7.3 Novartis Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Novartis Main Business Overview
13.7.5 Novartis Latest Developments
13.8 Eli Lilly
13.8.1 Eli Lilly Company Information
13.8.2 Eli Lilly Psoriasis Biologics Drugs Product Portfolios and Specifications
13.8.3 Eli Lilly Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Eli Lilly Main Business Overview
13.8.5 Eli Lilly Latest Developments
13.9 Sun Pharmaceutical
13.9.1 Sun Pharmaceutical Company Information
13.9.2 Sun Pharmaceutical Psoriasis Biologics Drugs Product Portfolios and Specifications
13.9.3 Sun Pharmaceutical Psoriasis Biologics Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Sun Pharmaceutical Main Business Overview
13.9.5 Sun Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
.
Table 1. Psoriasis Biologics Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Psoriasis Biologics Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTNF-? Inhibitor
Table 4. Major Players of IL-12/23Target Drug
Table 5. Major Players of IL-17Target Drug
Table 6. Global Psoriasis Biologics Drugs Sales byType (2020-2025) & (K Units)
Table 7. Global Psoriasis Biologics Drugs Sales Market Share byType (2020-2025)
Table 8. Global Psoriasis Biologics Drugs Revenue byType (2020-2025) & ($ million)
Table 9. Global Psoriasis Biologics Drugs Revenue Market Share byType (2020-2025)
Table 10. Global Psoriasis Biologics Drugs Sale Price byType (2020-2025) & (US$/Unit)
Table 11. Global Psoriasis Biologics Drugs Sale by Application (2020-2025) & (K Units)
Table 12. Global Psoriasis Biologics Drugs Sale Market Share by Application (2020-2025)
Table 13. Global Psoriasis Biologics Drugs Revenue by Application (2020-2025) & ($ million)
Table 14. Global Psoriasis Biologics Drugs Revenue Market Share by Application (2020-2025)
Table 15. Global Psoriasis Biologics Drugs Sale Price by Application (2020-2025) & (US$/Unit)
Table 16. Global Psoriasis Biologics Drugs Sales by Company (2020-2025) & (K Units)
Table 17. Global Psoriasis Biologics Drugs Sales Market Share by Company (2020-2025)
Table 18. Global Psoriasis Biologics Drugs Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Psoriasis Biologics Drugs Revenue Market Share by Company (2020-2025)
Table 20. Global Psoriasis Biologics Drugs Sale Price by Company (2020-2025) & (US$/Unit)
Table 21. Key Manufacturers Psoriasis Biologics Drugs Producing Area Distribution and Sales Area
Table 22. Players Psoriasis Biologics Drugs Products Offered
Table 23. Psoriasis Biologics Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Psoriasis Biologics Drugs Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Psoriasis Biologics Drugs Sales Market Share Geographic Region (2020-2025)
Table 28. Global Psoriasis Biologics Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Psoriasis Biologics Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Psoriasis Biologics Drugs Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Psoriasis Biologics Drugs Sales Market Share by Country/Region (2020-2025)
Table 32. Global Psoriasis Biologics Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Psoriasis Biologics Drugs Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Psoriasis Biologics Drugs Sales by Country (2020-2025) & (K Units)
Table 35. Americas Psoriasis Biologics Drugs Sales Market Share by Country (2020-2025)
Table 36. Americas Psoriasis Biologics Drugs Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Psoriasis Biologics Drugs Sales byType (2020-2025) & (K Units)
Table 38. Americas Psoriasis Biologics Drugs Sales by Application (2020-2025) & (K Units)
Table 39. APAC Psoriasis Biologics Drugs Sales by Region (2020-2025) & (K Units)
Table 40. APAC Psoriasis Biologics Drugs Sales Market Share by Region (2020-2025)
Table 41. APAC Psoriasis Biologics Drugs Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Psoriasis Biologics Drugs Sales byType (2020-2025) & (K Units)
Table 43. APAC Psoriasis Biologics Drugs Sales by Application (2020-2025) & (K Units)
Table 44. Europe Psoriasis Biologics Drugs Sales by Country (2020-2025) & (K Units)
Table 45. Europe Psoriasis Biologics Drugs Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Psoriasis Biologics Drugs Sales byType (2020-2025) & (K Units)
Table 47. Europe Psoriasis Biologics Drugs Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Psoriasis Biologics Drugs Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Psoriasis Biologics Drugs Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Psoriasis Biologics Drugs Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Psoriasis Biologics Drugs Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Psoriasis Biologics Drugs
Table 53. Key Market Challenges & Risks of Psoriasis Biologics Drugs
Table 54. Key IndustryTrends of Psoriasis Biologics Drugs
Table 55. Psoriasis Biologics Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Psoriasis Biologics Drugs Distributors List
Table 58. Psoriasis Biologics Drugs Customer List
Table 59. Global Psoriasis Biologics Drugs SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Psoriasis Biologics Drugs RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Psoriasis Biologics Drugs SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Psoriasis Biologics Drugs Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Psoriasis Biologics Drugs SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Psoriasis Biologics Drugs Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Psoriasis Biologics Drugs SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Psoriasis Biologics Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Psoriasis Biologics Drugs SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Psoriasis Biologics Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Psoriasis Biologics Drugs SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Psoriasis Biologics Drugs RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Psoriasis Biologics Drugs SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Psoriasis Biologics Drugs RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Amgen Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Amgen Psoriasis Biologics Drugs Product Portfolios and Specifications
Table 75. Amgen Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Amgen Main Business
Table 77. Amgen Latest Developments
Table 78. UCB Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. UCB Psoriasis Biologics Drugs Product Portfolios and Specifications
Table 80. UCB Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. UCB Main Business
Table 82. UCB Latest Developments
Table 83. Johnson & Johnson Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Johnson & Johnson Psoriasis Biologics Drugs Product Portfolios and Specifications
Table 85. Johnson & Johnson Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Johnson & Johnson Main Business
Table 87. Johnson & Johnson Latest Developments
Table 88. Abbive Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Abbive Psoriasis Biologics Drugs Product Portfolios and Specifications
Table 90. Abbive Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Abbive Main Business
Table 92. Abbive Latest Developments
Table 93. Innovent Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Innovent Psoriasis Biologics Drugs Product Portfolios and Specifications
Table 95. Innovent Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Innovent Main Business
Table 97. Innovent Latest Developments
Table 98. Biocad Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Biocad Psoriasis Biologics Drugs Product Portfolios and Specifications
Table 100. Biocad Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Biocad Main Business
Table 102. Biocad Latest Developments
Table 103. Novartis Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Novartis Psoriasis Biologics Drugs Product Portfolios and Specifications
Table 105. Novartis Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Novartis Main Business
Table 107. Novartis Latest Developments
Table 108. Eli Lilly Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Eli Lilly Psoriasis Biologics Drugs Product Portfolios and Specifications
Table 110. Eli Lilly Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Eli Lilly Main Business
Table 112. Eli Lilly Latest Developments
Table 113. Sun Pharmaceutical Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Sun Pharmaceutical Psoriasis Biologics Drugs Product Portfolios and Specifications
Table 115. Sun Pharmaceutical Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Sun Pharmaceutical Main Business
Table 117. Sun Pharmaceutical Latest Developments
.
Table 1. Psoriasis Biologics Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Psoriasis Biologics Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTNF-? Inhibitor
Table 4. Major Players of IL-12/23Target Drug
Table 5. Major Players of IL-17Target Drug
Table 6. Global Psoriasis Biologics Drugs Sales byType (2020-2025) & (K Units)
Table 7. Global Psoriasis Biologics Drugs Sales Market Share byType (2020-2025)
Table 8. Global Psoriasis Biologics Drugs Revenue byType (2020-2025) & ($ million)
Table 9. Global Psoriasis Biologics Drugs Revenue Market Share byType (2020-2025)
Table 10. Global Psoriasis Biologics Drugs Sale Price byType (2020-2025) & (US$/Unit)
Table 11. Global Psoriasis Biologics Drugs Sale by Application (2020-2025) & (K Units)
Table 12. Global Psoriasis Biologics Drugs Sale Market Share by Application (2020-2025)
Table 13. Global Psoriasis Biologics Drugs Revenue by Application (2020-2025) & ($ million)
Table 14. Global Psoriasis Biologics Drugs Revenue Market Share by Application (2020-2025)
Table 15. Global Psoriasis Biologics Drugs Sale Price by Application (2020-2025) & (US$/Unit)
Table 16. Global Psoriasis Biologics Drugs Sales by Company (2020-2025) & (K Units)
Table 17. Global Psoriasis Biologics Drugs Sales Market Share by Company (2020-2025)
Table 18. Global Psoriasis Biologics Drugs Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Psoriasis Biologics Drugs Revenue Market Share by Company (2020-2025)
Table 20. Global Psoriasis Biologics Drugs Sale Price by Company (2020-2025) & (US$/Unit)
Table 21. Key Manufacturers Psoriasis Biologics Drugs Producing Area Distribution and Sales Area
Table 22. Players Psoriasis Biologics Drugs Products Offered
Table 23. Psoriasis Biologics Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Psoriasis Biologics Drugs Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Psoriasis Biologics Drugs Sales Market Share Geographic Region (2020-2025)
Table 28. Global Psoriasis Biologics Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Psoriasis Biologics Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Psoriasis Biologics Drugs Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Psoriasis Biologics Drugs Sales Market Share by Country/Region (2020-2025)
Table 32. Global Psoriasis Biologics Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Psoriasis Biologics Drugs Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Psoriasis Biologics Drugs Sales by Country (2020-2025) & (K Units)
Table 35. Americas Psoriasis Biologics Drugs Sales Market Share by Country (2020-2025)
Table 36. Americas Psoriasis Biologics Drugs Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Psoriasis Biologics Drugs Sales byType (2020-2025) & (K Units)
Table 38. Americas Psoriasis Biologics Drugs Sales by Application (2020-2025) & (K Units)
Table 39. APAC Psoriasis Biologics Drugs Sales by Region (2020-2025) & (K Units)
Table 40. APAC Psoriasis Biologics Drugs Sales Market Share by Region (2020-2025)
Table 41. APAC Psoriasis Biologics Drugs Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Psoriasis Biologics Drugs Sales byType (2020-2025) & (K Units)
Table 43. APAC Psoriasis Biologics Drugs Sales by Application (2020-2025) & (K Units)
Table 44. Europe Psoriasis Biologics Drugs Sales by Country (2020-2025) & (K Units)
Table 45. Europe Psoriasis Biologics Drugs Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Psoriasis Biologics Drugs Sales byType (2020-2025) & (K Units)
Table 47. Europe Psoriasis Biologics Drugs Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Psoriasis Biologics Drugs Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Psoriasis Biologics Drugs Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Psoriasis Biologics Drugs Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Psoriasis Biologics Drugs Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Psoriasis Biologics Drugs
Table 53. Key Market Challenges & Risks of Psoriasis Biologics Drugs
Table 54. Key IndustryTrends of Psoriasis Biologics Drugs
Table 55. Psoriasis Biologics Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Psoriasis Biologics Drugs Distributors List
Table 58. Psoriasis Biologics Drugs Customer List
Table 59. Global Psoriasis Biologics Drugs SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Psoriasis Biologics Drugs RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Psoriasis Biologics Drugs SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Psoriasis Biologics Drugs Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Psoriasis Biologics Drugs SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Psoriasis Biologics Drugs Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Psoriasis Biologics Drugs SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Psoriasis Biologics Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Psoriasis Biologics Drugs SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Psoriasis Biologics Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Psoriasis Biologics Drugs SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Psoriasis Biologics Drugs RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Psoriasis Biologics Drugs SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Psoriasis Biologics Drugs RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Amgen Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Amgen Psoriasis Biologics Drugs Product Portfolios and Specifications
Table 75. Amgen Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Amgen Main Business
Table 77. Amgen Latest Developments
Table 78. UCB Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. UCB Psoriasis Biologics Drugs Product Portfolios and Specifications
Table 80. UCB Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. UCB Main Business
Table 82. UCB Latest Developments
Table 83. Johnson & Johnson Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Johnson & Johnson Psoriasis Biologics Drugs Product Portfolios and Specifications
Table 85. Johnson & Johnson Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Johnson & Johnson Main Business
Table 87. Johnson & Johnson Latest Developments
Table 88. Abbive Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Abbive Psoriasis Biologics Drugs Product Portfolios and Specifications
Table 90. Abbive Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Abbive Main Business
Table 92. Abbive Latest Developments
Table 93. Innovent Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Innovent Psoriasis Biologics Drugs Product Portfolios and Specifications
Table 95. Innovent Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Innovent Main Business
Table 97. Innovent Latest Developments
Table 98. Biocad Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Biocad Psoriasis Biologics Drugs Product Portfolios and Specifications
Table 100. Biocad Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Biocad Main Business
Table 102. Biocad Latest Developments
Table 103. Novartis Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Novartis Psoriasis Biologics Drugs Product Portfolios and Specifications
Table 105. Novartis Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Novartis Main Business
Table 107. Novartis Latest Developments
Table 108. Eli Lilly Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Eli Lilly Psoriasis Biologics Drugs Product Portfolios and Specifications
Table 110. Eli Lilly Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Eli Lilly Main Business
Table 112. Eli Lilly Latest Developments
Table 113. Sun Pharmaceutical Basic Information, Psoriasis Biologics Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Sun Pharmaceutical Psoriasis Biologics Drugs Product Portfolios and Specifications
Table 115. Sun Pharmaceutical Psoriasis Biologics Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Sun Pharmaceutical Main Business
Table 117. Sun Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Psoriasis Biologics Drugs
Figure 2. Psoriasis Biologics Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Psoriasis Biologics Drugs Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Psoriasis Biologics Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Psoriasis Biologics Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Psoriasis Biologics Drugs Sales Market Share by Country/Region (2024)
Figure 10. Psoriasis Biologics Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofTNF-? Inhibitor
Figure 12. Product Picture of IL-12/23Target Drug
Figure 13. Product Picture of IL-17Target Drug
Figure 14. Global Psoriasis Biologics Drugs Sales Market Share byType in 2025
Figure 15. Global Psoriasis Biologics Drugs Revenue Market Share byType (2020-2025)
Figure 16. Psoriasis Biologics Drugs Consumed in Hospital Pharmacies
Figure 17. Global Psoriasis Biologics Drugs Market: Hospital Pharmacies (2020-2025) & (K Units)
Figure 18. Psoriasis Biologics Drugs Consumed in Retail Pharmacies
Figure 19. Global Psoriasis Biologics Drugs Market: Retail Pharmacies (2020-2025) & (K Units)
Figure 20. Psoriasis Biologics Drugs Consumed in Online Pharmacies
Figure 21. Global Psoriasis Biologics Drugs Market: Online Pharmacies (2020-2025) & (K Units)
Figure 22. Global Psoriasis Biologics Drugs Sale Market Share by Application (2024)
Figure 23. Global Psoriasis Biologics Drugs Revenue Market Share by Application in 2025
Figure 24. Psoriasis Biologics Drugs Sales by Company in 2025 (K Units)
Figure 25. Global Psoriasis Biologics Drugs Sales Market Share by Company in 2025
Figure 26. Psoriasis Biologics Drugs Revenue by Company in 2025 ($ millions)
Figure 27. Global Psoriasis Biologics Drugs Revenue Market Share by Company in 2025
Figure 28. Global Psoriasis Biologics Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Psoriasis Biologics Drugs Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Psoriasis Biologics Drugs Sales 2020-2025 (K Units)
Figure 31. Americas Psoriasis Biologics Drugs Revenue 2020-2025 ($ millions)
Figure 32. APAC Psoriasis Biologics Drugs Sales 2020-2025 (K Units)
Figure 33. APAC Psoriasis Biologics Drugs Revenue 2020-2025 ($ millions)
Figure 34. Europe Psoriasis Biologics Drugs Sales 2020-2025 (K Units)
Figure 35. Europe Psoriasis Biologics Drugs Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Psoriasis Biologics Drugs Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Psoriasis Biologics Drugs Revenue 2020-2025 ($ millions)
Figure 38. Americas Psoriasis Biologics Drugs Sales Market Share by Country in 2025
Figure 39. Americas Psoriasis Biologics Drugs Revenue Market Share by Country (2020-2025)
Figure 40. Americas Psoriasis Biologics Drugs Sales Market Share byType (2020-2025)
Figure 41. Americas Psoriasis Biologics Drugs Sales Market Share by Application (2020-2025)
Figure 42. United States Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Psoriasis Biologics Drugs Sales Market Share by Region in 2025
Figure 47. APAC Psoriasis Biologics Drugs Revenue Market Share by Region (2020-2025)
Figure 48. APAC Psoriasis Biologics Drugs Sales Market Share byType (2020-2025)
Figure 49. APAC Psoriasis Biologics Drugs Sales Market Share by Application (2020-2025)
Figure 50. China Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. India Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Psoriasis Biologics Drugs Sales Market Share by Country in 2025
Figure 58. Europe Psoriasis Biologics Drugs Revenue Market Share by Country (2020-2025)
Figure 59. Europe Psoriasis Biologics Drugs Sales Market Share byType (2020-2025)
Figure 60. Europe Psoriasis Biologics Drugs Sales Market Share by Application (2020-2025)
Figure 61. Germany Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 62.France Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Psoriasis Biologics Drugs Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Psoriasis Biologics Drugs Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Psoriasis Biologics Drugs Sales Market Share by Application (2020-2025)
Figure 69. Egypt Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Psoriasis Biologics Drugs in 2025
Figure 75. Manufacturing Process Analysis of Psoriasis Biologics Drugs
Figure 76. Industry Chain Structure of Psoriasis Biologics Drugs
Figure 77. Channels of Distribution
Figure 78. Global Psoriasis Biologics Drugs Sales MarketForecast by Region (2026-2031)
Figure 79. Global Psoriasis Biologics Drugs Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Psoriasis Biologics Drugs Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Psoriasis Biologics Drugs Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Psoriasis Biologics Drugs Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Psoriasis Biologics Drugs Revenue Market ShareForecast by Application (2026-2031)
Figure 1. Picture of Psoriasis Biologics Drugs
Figure 2. Psoriasis Biologics Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Psoriasis Biologics Drugs Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Psoriasis Biologics Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Psoriasis Biologics Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Psoriasis Biologics Drugs Sales Market Share by Country/Region (2024)
Figure 10. Psoriasis Biologics Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofTNF-? Inhibitor
Figure 12. Product Picture of IL-12/23Target Drug
Figure 13. Product Picture of IL-17Target Drug
Figure 14. Global Psoriasis Biologics Drugs Sales Market Share byType in 2025
Figure 15. Global Psoriasis Biologics Drugs Revenue Market Share byType (2020-2025)
Figure 16. Psoriasis Biologics Drugs Consumed in Hospital Pharmacies
Figure 17. Global Psoriasis Biologics Drugs Market: Hospital Pharmacies (2020-2025) & (K Units)
Figure 18. Psoriasis Biologics Drugs Consumed in Retail Pharmacies
Figure 19. Global Psoriasis Biologics Drugs Market: Retail Pharmacies (2020-2025) & (K Units)
Figure 20. Psoriasis Biologics Drugs Consumed in Online Pharmacies
Figure 21. Global Psoriasis Biologics Drugs Market: Online Pharmacies (2020-2025) & (K Units)
Figure 22. Global Psoriasis Biologics Drugs Sale Market Share by Application (2024)
Figure 23. Global Psoriasis Biologics Drugs Revenue Market Share by Application in 2025
Figure 24. Psoriasis Biologics Drugs Sales by Company in 2025 (K Units)
Figure 25. Global Psoriasis Biologics Drugs Sales Market Share by Company in 2025
Figure 26. Psoriasis Biologics Drugs Revenue by Company in 2025 ($ millions)
Figure 27. Global Psoriasis Biologics Drugs Revenue Market Share by Company in 2025
Figure 28. Global Psoriasis Biologics Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Psoriasis Biologics Drugs Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Psoriasis Biologics Drugs Sales 2020-2025 (K Units)
Figure 31. Americas Psoriasis Biologics Drugs Revenue 2020-2025 ($ millions)
Figure 32. APAC Psoriasis Biologics Drugs Sales 2020-2025 (K Units)
Figure 33. APAC Psoriasis Biologics Drugs Revenue 2020-2025 ($ millions)
Figure 34. Europe Psoriasis Biologics Drugs Sales 2020-2025 (K Units)
Figure 35. Europe Psoriasis Biologics Drugs Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Psoriasis Biologics Drugs Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Psoriasis Biologics Drugs Revenue 2020-2025 ($ millions)
Figure 38. Americas Psoriasis Biologics Drugs Sales Market Share by Country in 2025
Figure 39. Americas Psoriasis Biologics Drugs Revenue Market Share by Country (2020-2025)
Figure 40. Americas Psoriasis Biologics Drugs Sales Market Share byType (2020-2025)
Figure 41. Americas Psoriasis Biologics Drugs Sales Market Share by Application (2020-2025)
Figure 42. United States Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Psoriasis Biologics Drugs Sales Market Share by Region in 2025
Figure 47. APAC Psoriasis Biologics Drugs Revenue Market Share by Region (2020-2025)
Figure 48. APAC Psoriasis Biologics Drugs Sales Market Share byType (2020-2025)
Figure 49. APAC Psoriasis Biologics Drugs Sales Market Share by Application (2020-2025)
Figure 50. China Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. India Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Psoriasis Biologics Drugs Sales Market Share by Country in 2025
Figure 58. Europe Psoriasis Biologics Drugs Revenue Market Share by Country (2020-2025)
Figure 59. Europe Psoriasis Biologics Drugs Sales Market Share byType (2020-2025)
Figure 60. Europe Psoriasis Biologics Drugs Sales Market Share by Application (2020-2025)
Figure 61. Germany Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 62.France Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Psoriasis Biologics Drugs Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Psoriasis Biologics Drugs Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Psoriasis Biologics Drugs Sales Market Share by Application (2020-2025)
Figure 69. Egypt Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Psoriasis Biologics Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Psoriasis Biologics Drugs in 2025
Figure 75. Manufacturing Process Analysis of Psoriasis Biologics Drugs
Figure 76. Industry Chain Structure of Psoriasis Biologics Drugs
Figure 77. Channels of Distribution
Figure 78. Global Psoriasis Biologics Drugs Sales MarketForecast by Region (2026-2031)
Figure 79. Global Psoriasis Biologics Drugs Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Psoriasis Biologics Drugs Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Psoriasis Biologics Drugs Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Psoriasis Biologics Drugs Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Psoriasis Biologics Drugs Revenue Market ShareForecast by Application (2026-2031)
